Exelixis Inc (EXEL) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2016-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2016-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2016-12-31..
Borrowing debt
Overview →Financial period ending 2016-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2016-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2016-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2016-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 189.12M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 0.00 USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 597.54M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | (m) | (m) | $189.12M | $0.00 | (m) | (m) | $597.54M | (m) |
| 2016-09-30 | (m) | (m) | $109.36M | $81.49M | (m) | (m) | $548.49M | (m) |
| 2016-06-30 | (m) | (m) | $107.50M | $288.56M | (m) | (m) | $477.14M | (m) |
| 2016-03-31 | (m) | (m) | $27.50M | $361.16M | (m) | (m) | $492.53M | (m) |
| 2015-12-31 | (m) | (m) | $0.00 | $381.44M | (m) | (m) | $332.34M | (m) |
| 2015-09-30 | (m) | (m) | $450.00K | $377.44M | (m) | (m) | $363.24M | (m) |
| 2015-06-30 | (m) | (m) | $0.00 | $371.22M | (m) | (m) | $248.78M | (m) |
| 2015-03-31 | (m) | (m) | $4.08M | $364.36M | (m) | (m) | $282.93M | (m) |
| 2014-12-31 | (m) | (m) | $99.26M | $262.39M | (m) | (m) | $327.96M | (m) |
| 2014-09-30 | (m) | (m) | $97.25M | $257.96M | (m) | (m) | $383.66M | (m) |
| 2014-06-30 | (m) | (m) | $95.28M | $253.69M | (m) | (m) | $440.63M | (m) |
| 2014-03-31 | (m) | (m) | $1.39M | $341.63M | (m) | (m) | $497.56M | (m) |
| 2013-12-31 | (m) | (m) | $11.76M | $335.48M | (m) | (m) | $503.29M | (m) |
| 2013-09-30 | (m) | (m) | $12.13M | $329.46M | (m) | (m) | $555.96M | (m) |
| 2013-06-30 | (m) | (m) | $12.55M | $323.59M | (m) | (m) | $612.08M | (m) |
| 2013-03-31 | (m) | (m) | $12.86M | $318.00M | (m) | (m) | $659.53M | (m) |
| 2012-12-31 | (m) | (m) | $13.17M | $322.57M | (m) | $411.44M | $721.10M | (m) |
| 2011-12-31 | (m) | (m) | $4.87M | $176.65M | (m) | $194.26M | $393.26M | (m) |
| 2010-12-31 | (m) | (m) | $37.75M | $170.71M | (m) | $162.66M | $360.79M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |